Inotek Pharmaceuticals Corp

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Inotek Pharmaceuticals Corp
CIK #0001281895
EDGAR Form CIK 2011 - 2026
10-K [0001281895]
10-Q [0001281895]
3 [0001281895]
4 [0001281895]
5 [0001281895]
8-K [0001281895]
SC 13D [0001281895]
SC 13G [0001281895]
Form 13D/13G Filer Form 13D/13G Subject Filed
Maverick Capital Ltd Rocket Pharmaceuticals Inc [2025-04-14]
Wellington Management Group LLP Rocket Pharmaceuticals Inc [2024-02-08]
State Street Corp Rocket Pharmaceuticals Inc [2023-01-31]
Vanguard Group Inc Rocket Pharmaceuticals Inc [2022-02-10]
BlackRock Inc Rocket Pharmaceuticals Inc [2022-02-04]
Wellington Management Group LLP Rocket Pharmaceuticals Inc [2022-02-04]
Perceptive Advisors LLC Rocket Pharmaceuticals Inc [2021-02-16]
Price T Rowe Associates Inc /MD/ Rocket Pharmaceuticals Inc [2021-02-16]
Adage Capital Partners GP LLC Rocket Pharmaceuticals Inc [2019-01-17]
Boxer Capital LLC Rocket Pharmaceuticals Inc [2018-01-19]
View All
Form 3/4/5 Subject 2011 - 2026
Rocket Pharmaceuticals Inc
Manhede Joseph
Wong Roderick
Boess Carsten
Dolsten Mikael
Malik Fady Ibraham
Southwell David P
Fong Peter
Militello John
Shah Gaurav
Wilson Martin
Chaudhuri Sarbani
Rizvi Syed Ali-aamir
Stevens Christopher James
Bjork Elisabeth
Schwartz Jonathan David
Pratumsuwan Piratip
Granadillo Pedro P
Makker Gotham
Ondrey Aaron
Patel Kinnari
RTW Investments LP
White Mark Andrew
Yalamanchi Naveen
Woods Keith
Garcia-Parada Carlos
Alam Kamran
Batchelder Brian
Ritter Dale
Machado Patrick
Barberich Timothy J
Howes Paul G
Phillips Gary M
Carroll J Martin
Spivey Richard N
Baumgartner Rudolf A
Devon Park BioVentures LP
Devon Park Associates LLC
Devon Park Associates LP
McVicar William K
Rho Ventures IV-A LP
Rho Ventures IV Holdings LLC
Kantesaria Devang
Vogelbaum Martin
Harel Ittai
Karabelas Argeris N
Peimer Isai
Care Capital II LLC
Care Capital Offshore Investments III LP
Care Capital Investments II LP
Care Capital III LLC
Care Capital Offshore Investments II LP
Care Capital Investments III LP
MedImmune Ventures Inc
Pitango VC Fund IV LP
Pitango Venture Capital Fund IV LP
Pitango GC Capital Holdings Ltd
Pitango Venture Capital Principals Fund IV LP
Rho Capital Partners Verwaltungs GmbH
Rho Management Ventures IV LLC
Rho Ventures IV QP LP
Rho Ventures IV GmbH & Co Beteiligungs KG
Ruch Joshua
Kairouz Habib
Rho Ventures IV LP
Leschly Mark
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Rocket Pharmaceuticals Inc RCKT
Common Stock
2026-02-18 Sell 5,990 $3.34 20,007
Rocket Pharmaceuticals Inc RCKT
Common Stock
2026-02-18 Sell 1,376 $3.34 4,596
Rocket Pharmaceuticals Inc RCKT
Common Stock
2026-02-18 Sell 1,157 $3.34 3,864
Rocket Pharmaceuticals Inc RCKT
Common Stock
2026-02-13 Sell 12,253 $3.31 40,557
Rocket Pharmaceuticals Inc RCKT
Common Stock
2026-02-13 Sell 12,279 $3.31 40,643
Rocket Pharmaceuticals Inc RCKT
Common Stock
2026-02-13 Sell 3,726 $3.31 12,333
Rocket Pharmaceuticals Inc RCKT
Common Stock
2026-02-11 Grant 61,963 $0.00
Rocket Pharmaceuticals Inc RCKT
Common Stock
2026-02-11 Grant 311,813 $0.00
Rocket Pharmaceuticals Inc RCKT
Stock Option (Right to Buy) · derivative
2026-02-11 Grant 468,187 $0.00
Rocket Pharmaceuticals Inc RCKT
Stock Option (right to buy) · derivative
2026-02-11 Grant 93,037 $0.00
Rocket Pharmaceuticals Inc RCKT
Common Stock
2026-02-11 Grant 61,963 $0.00
Rocket Pharmaceuticals Inc RCKT
Common Stock
2026-02-11 Grant 286,028 $0.00
Rocket Pharmaceuticals Inc RCKT
Common Stock
2026-02-11 Grant 125,924 $0.00
Rocket Pharmaceuticals Inc RCKT
Stock Option (Right to Buy) · derivative
2026-02-11 Grant 870,648 $0.00
Rocket Pharmaceuticals Inc RCKT
Stock Option (Right to Buy) · derivative
2026-02-11 Grant 189,076 $0.00
Rocket Pharmaceuticals Inc RCKT
Stock Option (Right to Buy) · derivative
2026-02-11 Grant 45,018 $0.00
Rocket Pharmaceuticals Inc RCKT
Common Stock
2026-02-11 Grant 29,982 $0.00
Rocket Pharmaceuticals Inc RCKT
Stock Option (Right to Buy) · derivative
2026-02-11 Grant 93,037 $0.00
Rocket Pharmaceuticals Inc RCKT
Common Stock
2026-01-02 Buy 10,000 $3.44 34,400
Rocket Pharmaceuticals Inc RCKT
Common Stock
2025-11-18 Sell 1,646 $2.98 4,905
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com